We’re backed by science from New Zealand’s leading plant geneticists and pharmacologists, and we’re implementing a business model designed to give us the lowest cost-base in the industry.
Our aim is to provide a range of products that will allow the average medical cannabis user in New Zealand to access the safest and most affordable products available for less than the global average monthly spend.